Improving the therapeutic benefits of ipilimumab

Oncology (Williston Park). 2010 Dec;24(14):1288, 1294.

Authors

Sumit K Subudhi¹, Margaret K Callahan, Jedd D Wolchok

Affiliation

¹ Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

PMID: 21294472

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Antigens, CD*
CTLA-4 Antigen
Humans
Immunotherapy
Ipilimumab
Melanoma / drug therapy*
Melanoma / immunology
Proto-Oncogene Proteins B-raf / antagonists & inhibitors

Substances

Antibodies, Monoclonal
Antigens, CD
CTLA-4 Antigen
CTLA4 protein, human
Ipilimumab
BRAF protein, human
Proto-Oncogene Proteins B-raf